{"nct_id":"NCT00463788","title":"Cetuximab and Cisplatin in the Treatment of \"Triple Negative\" (Estrogen Receptor [ER] Negative, Progesterone Receptor [PgR] Negative, and Human Epidermal Growth Factor Receptor 2 [HER2] Negative) Metastatic Breast Cancer","status":"COMPLETED","status_verified_date":"2014-01","start_date":"2007-06","start_date_type":null,"primary_completion_date":"2009-07","primary_completion_date_type":"ACTUAL","completion_date":"2011-02","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}